Scinus Cell Expansion Netherlands B.V.
Scinus Cell Expansion is a biotech company, developing innovative technologies for cell production. Our mission is to make cell therapies accessible for a global patient population. The core activity is the development and marketing of an innovative bioreactor platform technology for the cell culture industry.
The SCINUS bioreactor offers a cost-effective, controlled alternative to conventional cell production strategies. The patented technology allows cell culture professionals to perform the entire cell expansion process, for both adherent and suspension cells, within one closed system. Therefore, our bioreactor technology is ideal for scale out of (stem) cell culture.
Scinus Cell Expansion Netherlands B.V. also offers services to assist its clients in the translation to a commercial scale GMP production strategy for their cell products.
Team member information
Ruud Das is CSO and Manager Operations at Scinus Cell Expansion Netherlands BV. He has extensive experience in the use of bioreactor technology for regenerative medicine and cell therapy applications. He obtained his PhD at the Erasmus Medical Center in Rotterdam, The Netherlands, developing and using bioreactor technology for cartilage tissue engineering applications. Since then, he has been involved in the development of the Scinus Bioreactor system and its applications. Ruud been involved in and led multiple international research projects that advanced the use and capabilities of Scinus’s proprietary technology.